Circadian-timed combination doxorubicin-cisplatin chemotherapy for advanced endometrial carcinoma: A Phase II study of the Gynecologic Oncology Group

R. J. Barrett, J. A. Blessing, H. D. Homesley, L. Twiggs, K. D. Webster

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Fingerprint Dive into the research topics of 'Circadian-timed combination doxorubicin-cisplatin chemotherapy for advanced endometrial carcinoma: A Phase II study of the Gynecologic Oncology Group'. Together they form a unique fingerprint.

Medicine & Life Sciences